DePuy Synthes Acquires CrossRoads® Extremity Systems to Further Strengthen Elective Foot & Ankle Portfolio
Innovative Elective Foot & Ankle Products Will Provide Surgeons with Multiple Options to Address Growing Patient Need
WEST CHESTER, PA – February 10, 2022 – Today, the Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has acquired CrossRoads® Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications. Private equity firm HealthpointCapital was the majority investor and worked with the CrossRoads® team to develop the company into a growth leader in foot and ankle. This acquisition further demonstrates DePuy Synthes’ commitment to driving orthopaedic, podiatric and medtech advancements through both internal and external innovation to deliver industry-leading technology that improves patient lives.
“At DePuy Synthes, we look at innovation with one goal in mind: to bring differentiated solutions to market to address the unmet needs of surgeons and patients around the world,” said Oray ...
